Genomma Lab Internacional, S.A.B. de C.V. Stock
Stocks
LAB B
MX01LA010006
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Mexican S.E.
28/10/2026
|
5-day change | 1st Jan Change | ||
| 14.48 MXN | -6.10% |
|
+1.47% | -19.06% |
| Market Cap | 15.01B 804M 722M 667M 604M 1.13B 76.62B 1.14B 7.98B 3.18B 40.09B 3.02B 2.96B 127B | P/E 2026 * |
7.44x | P/E 2027 * | 7.33x |
|---|---|---|---|---|---|
| Enterprise Value | 19.2B 1.03B 923M 854M 773M 1.44B 98.01B 1.46B 10.21B 4.06B 51.28B 3.86B 3.78B 163B | EV / Sales 2026 * |
1.08x | EV / Sales 2027 * | 1x |
| Free-Float |
68.95% | Yield 2026 * |
5.53% | Yield 2027 * | 7.4% |
| Markets | Quality | ||
|---|---|---|---|
Mexican S.E.
| LAB B | End-of-day quote | |
OTC Markets
| GNMLF | Delayed | |
|
Deutsche Boerse AG
| GEKA | Delayed |
Last Transcript: Genomma Lab Internacional, S.A.B. de C.V.
| 1 day | -6.10% | ||
| 1 week | +1.47% | ||
| Current month | +15.19% | ||
| 1 month | +12.68% | ||
| 3 months | -0.55% | ||
| 6 months | -13.03% | ||
| Current year | -19.06% |
| 1 week | 14.15 |  | 15.75 |
| 1 month | 12.37 | | 15.75 |
| Current year | 12.22 | | 19.48 |
| 1 year | 12.22 | | 19.48 |
| 3 years | 12.22 | | 29.18 |
| 5 years | 12.22 | | 29.18 |
| 10 years | 11.1 | | 29.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | 12/04/2023 |
| Director of Finance/CFO | - | 01/12/2015 | |
| Investor Relations Contact | - | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/10/1996 | |
Juan Alonso
BRD | Director/Board Member | - | 06/07/2010 |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.10% | +1.47% | -21.73% | +9.20% | 804M | |
| +0.50% | +0.36% | +55.89% | +129.96% | 1,143B | |
| +0.86% | +4.50% | +42.43% | +86.15% | 647B | |
| -0.14% | -1.07% | +25.42% | +105.85% | 506B | |
| -0.05% | +2.28% | +49.14% | +67.74% | 384B | |
| -0.63% | -4.97% | +60.15% | +37.06% | 350B | |
| +0.34% | +2.15% | +25.26% | +54.27% | 293B | |
| -0.45% | +1.16% | +1.74% | +26.08% | 265B | |
| +0.87% | +2.94% | +55.18% | +72.74% | 242B | |
| +0.08% | +1.72% | +32.15% | +107.78% | 197B | |
| Average | -0.25% | +0.62% | +32.56% | +69.68% | 402.83B | |
| Weighted average by Cap. | +0.71% | +0.71% | +42.62% | +89.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17.81B 954M 856M 792M 717M 1.34B 90.89B 1.36B 9.46B 3.77B 47.56B 3.58B 3.51B 151B | 18.74B 1B 901M 833M 755M 1.41B 95.66B 1.43B 9.96B 3.97B 50.06B 3.77B 3.69B 159B |
| Net income | 1.95B 105M 93.8M 86.73M 78.54M 147M 9.96B 149M 1.04B 413M 5.21B 392M 384M 16.54B | 2.06B 110M 98.96M 91.49M 82.86M 155M 10.51B 157M 1.09B 436M 5.5B 414M 405M 17.45B |
| Net Debt | 4.19B 225M 201M 186M 169M 315M 21.39B 319M 2.23B 887M 11.19B 843M 825M 35.53B | 3.67B 196M 176M 163M 148M 276M 18.71B 279M 1.95B 776M 9.79B 737M 722M 31.08B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | MX$14.48 | -6.10% | 3,990,287 |
| 27/10/26 | MX$15.42 | -1.53% | 12,642,171 |
| 26/10/26 | MX$15.66 | +2.15% | 3,725,217 |
| 23/10/26 | MX$15.33 | +4.43% | 4,189,281 |
| 22/10/26 | MX$14.68 | +2.09% | 3,063,954 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LAB B Stock
Select your edition
All financial news and data tailored to specific country editions
